1-3 of 3
Michelle Detry, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fludarabine, Cyclophosphamide, Mitoxantrone Plus Rituximab (FCM-R) as Frontline Therapy for CLL: Results of a Phase 2 Study.

Stefan Faderl, MD, William G. Wierda, MD PhD, Susan O’Brien, MD, Alessandra Ferrajoli, MD, Farhad Ravandi-Kashani, MD, Michelle Detry, PhD, Hagop M. Kantarjian, MD, Brandi O’Neal, RN, Michael J. Keating, MB BS
Journal: Blood
Blood (2006) 108 (11): 2836.
https://doi.org/10.1182/blood.V108.11.2836.2836
Published: 2006
Journal Articles

Long-Term Follow-Up of Allogeneic Stem Cell Transplantation (SCT) with Reduced Intensity Conditioning (RIC) for Patients (pts) with Chronic Myeloid Leukemia (CML).

Partow Kebriaei, MD, Michelle Detry, PhD, Antonio Carrasco-Yalan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Issa Khouri, MD, Paolo Anderlini, MD, Chitra Hosing, MD, Amin Alousi, MD, Sergio Giralt, MD, Richard Champlin, MD, Marcos de Lima, MD
Journal: Blood
Blood (2006) 108 (11): 2898.
https://doi.org/10.1182/blood.V108.11.2898.2898
Published: 2006
Journal Articles

Infections in Patients with Chronic Lymphocytic Leukemia Treated with Chemoimmunotherapy.

Marina Motta, MD, William Wierda, MD, PhD, Susan O’Brien, MD, Stefan Faderl, MD, Alessandra Ferrajoli, MD, Michelle Detry, PhD, Susan Lerner, MS, Hagop Kantarjian, MD, Michael Keating, MB, BS
Journal: Blood
Blood (2005) 106 (11): 720.
https://doi.org/10.1182/blood.V106.11.720.720
Published: 2005